Today’s Solutions: June 11, 2026

Breast cancer research just had a major breakthrough, and it was completely unexpected. Doctors at the Institute of Cancer Research in London tested a pair of drugs targeting a specific weakness found in one-in-ten breast cancers on 257 women, and were stunned when they found that the cancer had disappeared or shrunken dramatically in many of the women. What’s even more incredible is that these results came 11 days after the trial had started. In 11 percent of the cases the cancer had completely disappeared, and in a further 17 percent they were smaller than 5mm. The drugs were lapantinib and trastuzumab, which both target HER2 – a protein that fuels the growth of some women’s cancers.

Solutions News Source Print this article
More of Today's Solutions

Dinner scraps are rebuilding California’s lost oyster reefs

BY THE OPTIMIST DAILY EDITORIAL TEAM What if scraps from a dinner could become a habitat? That's the basic premise of the Shells for ...

Read More

5 habits that separate growing teams from stagnant ones

BY THE OPTIMIST DAILY EDITORIAL TEAM The strategy is fine. The team is capable. But at the end of the quarter, the needle hasn’t ...

Read More

How a rickshaw driver’s son beat the odds to join a famed UK ballet school

Kamal Singh was 17-years-old when he first became transfixed by ballet dancers in a Bollywood film. At that moment, the son of a rickshaw ...

Read More

Food sequencing: how eating in the right order can boost your health

BY THE OPTIMIST DAILY EDITORIAL TEAM When we think about balanced eating, most of us focus on what’s on our plate—fiber, protein, vitamins, and ...

Read More